BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Govindappa PK, Patil M, Garikipati VNS, Verma SK, Saheera S, Narasimhan G, Zhu W, Kishore R, Zhang J, Krishnamurthy P. Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart. FASEB J 2020;34:2238-51. [PMID: 31907992 DOI: 10.1096/fj.201901995R] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Y, Zha F, Tang B, Ji TT, Li XY, Feng L, Bai SJ. Exosomal hsa_circ_0125310 promotes cell proliferation and fibrosis in diabetic nephropathy via sponging miR-422a and targeting the IGF1R/p38 axis. J Cell Mol Med 2021. [PMID: 34854210 DOI: 10.1111/jcmm.17065] [Reference Citation Analysis]
2 Guo D, Xu Y, Ding J, Dong J, Jia N, Li Y, Zhang M. Roles and Clinical Applications of Exosomes in Cardiovascular Disease. Biomed Res Int 2020;2020:5424281. [PMID: 32596327 DOI: 10.1155/2020/5424281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Brigstock DR. Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. Cells 2021;10:1596. [PMID: 34202136 DOI: 10.3390/cells10071596] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Ren Y, Yang M, Wang X, Xu B, Xu Z, Su B. ELAV-like RNA binding protein 1 regulates osteogenesis in diabetic osteoporosis: Involvement of divalent metal transporter 1. Mol Cell Endocrinol 2022;:111559. [PMID: 35051552 DOI: 10.1016/j.mce.2022.111559] [Reference Citation Analysis]
5 Jiang W, Xiong Y, Li X, Yang Y. Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles. Front Cardiovasc Med 2021;8:715258. [PMID: 34485413 DOI: 10.3389/fcvm.2021.715258] [Reference Citation Analysis]
6 Patil M, Saheera S, Dubey PK, Kahn-Krell A, Kumar Govindappa P, Singh S, Tousif S, Zhang Q, Lal H, Zhang J, Qin G, Krishnamurthy P. Novel Mechanisms of Exosome-Mediated Phagocytosis of Dead Cells in Injured Heart. Circ Res 2021;129:1006-20. [PMID: 34623174 DOI: 10.1161/CIRCRESAHA.120.317900] [Reference Citation Analysis]
7 Dubey S, Dubey PK, Umeshappa CS, Ghebre YT, Krishnamurthy P. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts. Journal Cellular Physiology. [DOI: 10.1002/jcp.30684] [Reference Citation Analysis]
8 Xia W, Chen H, Chen D, Ye Y, Xie C, Hou M. PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor-related cardiac dysfunction. J Immunother Cancer 2020;8:e001293. [PMID: 33115945 DOI: 10.1136/jitc-2020-001293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hohn J, Tan W, Carver A, Barrett H, Carver W. Roles of Exosomes in Cardiac Fibroblast Activation and Fibrosis. Cells 2021;10:2933. [PMID: 34831158 DOI: 10.3390/cells10112933] [Reference Citation Analysis]
10 Shi C, Xie H, Ma Y, Yang Z, Zhang J. Nanoscale Technologies in Highly Sensitive Diagnosis of Cardiovascular Diseases. Front Bioeng Biotechnol 2020;8:531. [PMID: 32582663 DOI: 10.3389/fbioe.2020.00531] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhang D, Wu Y, Li Z, Chen H, Huang S, Jian C, Yu A. MiR-144-5p, an exosomal miRNA from bone marrow-derived macrophage in type 2 diabetes, impairs bone fracture healing via targeting Smad1. J Nanobiotechnology 2021;19:226. [PMID: 34340698 DOI: 10.1186/s12951-021-00964-8] [Reference Citation Analysis]
12 Wang Y, Zhao M, Liu S, Guo J, Lu Y, Cheng J, Liu J. Macrophage-derived extracellular vesicles: diverse mediators of pathology and therapeutics in multiple diseases. Cell Death Dis 2020;11:924. [PMID: 33116121 DOI: 10.1038/s41419-020-03127-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]